Azathioprine induced acute interstitial nephritis as the cause of rapidly progressive renal failure in a patient with Wegener's granulomatosis

Journal of Rheumatology

Volumn 33, Issue 1, 2006, Pages 185-187

  Bir, Karen ^a,b   Herzenberg, Andrew M ^a,b   Carette, Simon ^a,c,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b Department of Pathology ^*  (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Azathioprine; Interstitial nephritis; Vasculitis; Wegener's granulomatosis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; METHOTREXATE; METHYLPREDNISOLONE; OMEPRAZOLE; PREDNISONE; RAMIPRIL; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; DRUG HYPERSENSITIVITY; FEMALE; FEVER; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY FAILURE; LOW BACK PAIN; NAUSEA; OLIGURIA; PRIORITY JOURNAL; SYMPTOM; URINE SEDIMENT; VOMITING; WEGENER GRANULOMATOSIS;

ACUTE DISEASE; AZATHIOPRINE; DIAGNOSIS, DIFFERENTIAL; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE; MIDDLE AGED; NEPHRITIS, INTERSTITIAL; WEGENER GRANULOMATOSIS; WITHHOLDING TREATMENT;

EID: 30144445033     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Cush J, Kavanaugh A. Rheumatology: Diagnosis and therapeutics. Baltimore: Lippincott Williams and Wilkins; 1999:381-5.
2. Baker RJ, Pusey CD. The changing profile of acute tubulo interstitial nephritis. Nephrol Dial Transplant 2004;19:8-11.
3. Gearry RB, Barclay ML, Burt MJ, et al. Thiopurine 5-methyltransferase genotype does not predict adverse drug reaction to thiopurine drugs in patients with IBD. Aliment Pharmacol Ther 2003;18:395-400.
4. Singh G, Fries JF, Spitz P, Williams CA. Toxic effects of azathioprine in rheumatoid arthritis: a national post-marketing perspective. Arthritis Rheum 1989;32:837-43.
5. Dominguez Ortega J, Robledo T, Martinez Cocera C, Alonso A, Cimarra M, Plaza A. Desensitization to azathioprine. J Invest Allerg Clin Immunol 1999;9:337-8.
6. Garey KW, Streetman DS, Rainish MC. Azathioprine hypersensitivity reaction in a patient with ulcerative colitis. Ann Pharmacother 1998;32:425-8.
7. Schmitt K, Pfeiffer U, Stiehrle HE, Thuermann PA. Absence of AZA hypersensitivity after administration of its active metabolite 6-mercaptopurine. Acta Dermatol Venereol 2000;80:147-8.
8. Jeurissen M, Boerbooms AM, van de Putte LBA, Kruijsen MW. Azathioprine induced fever, chills, rash and hepatotoxicity in RA. Ann Rheum Dis 1990;49:25-7.
9. Meys E, Devogelaer JP, Geubel A, Rahier J, Nagant de Deuxchaisnes C. Fever, hepatitis, and acute interstitial nephritis in a patient with RA. Concurrent manifestations of AZA hypersensitivity. J Rheumatol 1992;19:807-9.
10. Sinico R, Sabadini E, Borlandelli S, Cosci P, Di Toma L, Imbasciati E. Azathioprine hypersensitivity: Report of two cases and review of literature. J Nephrol 2003;16:272-6.
11. Reinhold-Keller E, Schmitt WH, Gross WL. AZA toxicity mimicking a relapse of Wegener's granulomatosis. Rheumatology Oxford 2001;40:831-2.
12. Rossert J. Drug-induced acute interstitial nephritis. Kidney Int 2001;60:804-17.
13. Black AJ, McLeod HL, Capell HA, et al. Thiopurine methyltransferase genotype predicts therapy limiting severe toxicity from azathioprine. Ann Intern Med 1998;29:716-8.
14. Clunie GP, Lennard L. Relevance of thiopurine methyltransferase status in rheumatic patients receiving AZA. Rheumatology Oxford 2004;43:13-8.